Alejandra Lopez-Giraldo
Overview
Explore the profile of Alejandra Lopez-Giraldo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia Castillo E, Vargas G, Garcia Guerra J, Lopez-Giraldo A, Alonso Perez T
Open Respir Arch
. 2023 Jul;
4(2):100171.
PMID: 37497315
Chronic Obstructive Pulmonary Disease (COPD) is related to smoking as the main etiological agent although there are other risk factors that can interact influencing the development of the disease. The...
2.
Agusti A, De Stefano G, Levi A, Munoz X, Romero-Mesones C, Sibila O, et al.
Eur Respir J
. 2022 Feb;
59(3).
PMID: 35144989
No abstract available.
3.
Casas-Recasens S, Mendoza N, Lopez-Giraldo A, Garcia T, Cosio B, Pascual-Guardia S, et al.
Front Med (Lausanne)
. 2021 Dec;
8:761767.
PMID: 34901077
Accelerated ageing is implicated in the pathogenesis of respiratory diseases as chronic obstructive pulmonary disease (COPD), but recent evidence indicates that the COPD can have roots early in life. Here...
4.
Mathioudakis A, Abroug F, Agusti A, Ananth S, Bakke P, Bartziokas K, et al.
Eur Respir J
. 2021 Oct;
59(5).
PMID: 34649975
Clinical trials evaluating the management of acute exacerbations of COPD assess heterogeneous outcomes, often omitting those that are clinically relevant or more important to patients. We have developed a core...
5.
Agusti A, Sibila O, Casas-Recasens S, Mendoza N, Perea L, Lopez-Giraldo A, et al.
Ann Am Thorac Soc
. 2021 May;
18(11):1922-1924.
PMID: 33950792
No abstract available.
6.
Mathioudakis A, Abroug F, Agusti A, Bakke P, Bartziokas K, Beghe B, et al.
ERJ Open Res
. 2020 Sep;
6(3).
PMID: 32964006
Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A...
7.
Casas-Recasens S, Noell G, Mendoza N, Lopez-Giraldo A, Garcia T, Guirao A, et al.
Am J Respir Crit Care Med
. 2020 Aug;
203(1):129-134.
PMID: 32822219
No abstract available.
8.
Cruz T, Lopez-Giraldo A, Noell G, Casas-Recasens S, Garcia T, Molins L, et al.
Respir Res
. 2019 Jul;
20(1):152.
PMID: 31299954
Background: Chronic Obstructive Pulmonary Disease (COPD) is associated with an abnormal pulmonary and systemic immune response to tobacco smoking. Yet, how do immune cells relate within and between these two...
9.
Cruz T, Lopez-Giraldo A, Noell G, Guirao A, Casas-Recasens S, Garcia T, et al.
Am J Respir Cell Mol Biol
. 2019 Apr;
61(5):575-583.
PMID: 30978114
Tobacco smoking is the main environmental risk factor for chronic obstructive pulmonary disease (COPD), but not all smokers develop the disease. A population of lung-resident mesenchymal stem cells (LR-MSCs) exist...
10.
Faner R, Morrow J, Casas-Recasens S, Cloonan S, Noell G, Lopez-Giraldo A, et al.
Respir Res
. 2019 Jan;
20(1):5.
PMID: 30621695
Background: Previous studies have identified lung, sputum or blood transcriptomic biomarkers associated with the severity of airflow limitation in COPD. Yet, it is not clear whether the lung pathobiology is...